First Wave BioPharma Analyst Ratings
First Wave BioPharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/03/2023 | 231.49% | HC Wainwright & Co. | → $18 | Reiterates | → Buy |
| 01/31/2023 | 231.49% | HC Wainwright & Co. | → $18 | Reiterates | → Buy |
| 01/26/2023 | 231.49% | HC Wainwright & Co. | → $18 | Reiterates | → Buy |
| 12/02/2022 | -26.34% | HC Wainwright & Co. | $8 → $4 | Maintains | Buy |
| 05/26/2022 | 65.75% | Roth Capital | $20 → $9 | Maintains | Buy |
| 12/07/2021 | — | Maxim Group | Downgrades | Buy → Hold |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 02/03/2023 | 231.49% | HC Wainwright & Co. | → 18 美元 | 重申 | → 购买 |
| 01/31/2023 | 231.49% | HC Wainwright & Co. | → 18 美元 | 重申 | → 购买 |
| 01/26/2023 | 231.49% | HC Wainwright & Co. | → 18 美元 | 重申 | → 购买 |
| 12/02/2022 | -26.34% | HC Wainwright & Co. | 8 美元 → 4 美元 | 维护 | 购买 |
| 05/26/2022 | 65.75% | 罗斯资本 | 20 美元 → 9 美元 | 维护 | 购买 |
| 2021 年 7 月 12 日 | — | Maxim 集团 | 降级 | 买入 → 持有 |
What is the target price for First Wave BioPharma (FWBI)?
First Wave BioPharma（FWBI）的目标价格是多少？
The latest price target for First Wave BioPharma (NASDAQ: FWBI) was reported by HC Wainwright & Co. on February 3, 2023. The analyst firm set a price target for $18.00 expecting FWBI to rise to within 12 months (a possible 231.49% upside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年2月3日公布了First Wave BioPharma（纳斯达克股票代码：FWBI）的最新目标股价。这家分析公司将目标股价定为18.00美元，预计FWBI将在12个月内升至18.00美元（可能上涨231.49％）。去年有5家分析公司公布了评级。
What is the most recent analyst rating for First Wave BioPharma (FWBI)?
First Wave BioPharma（FWBI）的最新分析师评级是多少？
The latest analyst rating for First Wave BioPharma (NASDAQ: FWBI) was provided by HC Wainwright & Co., and First Wave BioPharma reiterated their buy rating.
First Wave BioPharma（纳斯达克股票代码：FWBI）的最新分析师评级由HC Wainwright & Co. 提供，First Wave BioPharma重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for First Wave BioPharma (FWBI)?
First Wave BioPharma（FWBI）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of First Wave BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for First Wave BioPharma was filed on February 3, 2023 so you should expect the next rating to be made available sometime around February 3, 2024.
分析师在进行了广泛的研究，包括浏览公开财务报表、与First Wave BioPharma的高管和客户交谈以及听取财报电话会议后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。First Wave BioPharma的最后一次评级是在2023年2月3日提交的，因此你应该预计下一个评级将在2024年2月3日左右公布。
Is the Analyst Rating First Wave BioPharma (FWBI) correct?
分析师对First Wave BioPharma（FWBI）的评级正确吗？
While ratings are subjective and will change, the latest First Wave BioPharma (FWBI) rating was a reiterated with a price target of $0.00 to $18.00. The current price First Wave BioPharma (FWBI) is trading at is $5.43, which is within the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的First Wave BioPharma（FWBI）评级得到了重申，目标股价为0.00美元至18.00美元。First Wave BioPharma（FWBI）目前的交易价格为5.43美元，在分析师的预测区间内。